Quality of bevacizumab compounded for intravitreal administration.

Palmer JM, Amoaku WM, Kamali F

A novel automethylation reaction in the Aspergillus nidulans LaeA protein generates S-methylmethionine.

Patananan AN, Palmer JM, Garvey GS, Keller NP, Clarke SG

RsmA regulates Aspergillus fumigatus gliotoxin cluster metabolites including cyclo(L-Phe-L-Ser), a potential new diagnostic marker for invasive aspergillosis.

Sekonyela R, Palmer JM, Bok JW, Jain S, Berthier E, Forseth R, Schroeder F, Keller NP

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.

Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, Catricalà C, Dalle S, Duval-Modeste AB, Ghiorzo P, Grammatico P, Harland M, Hayward NK, Hu HH, Jouary T, Martin-Denavit T, Ozola A, Palmer JM, Pastorino L, Pjanova D, Soufir N, Steine SJ, Stratigos AJ, Thomas L, Tinat J, Tsao H, Veinalde R, Tucker MA, Bressac-de Paillerets B, Newton-Bishop JA, Goldstein AM, Akslen LA, Molven A

Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus.

Palmer JM, Bok JW, Lee S, Dagenais TRT, Andes DR, Kontoyiannis DP, Keller NP

IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration.

Kumar P, Rajasekaran K, Palmer JM, Thakar MS, Malarkannan S

Clinical relevance of natural killer cells following hematopoietic stem cell transplantation.

Palmer JM, Rajasekaran K, Thakar MS, Malarkannan S

Secondary metabolism and development is mediated by LlmF control of VeA subcellular localization in Aspergillus nidulans.

Palmer JM, Theisen JM, Duran RM, Grayburn WS, Calvo AM, Keller NP

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.

Palmer JM, Lee SJ, Chai X, Storer BE, Flowers ME, Schultz KR, Inamoto Y, Cutler C, Pidala J, Arora M, Jacobsohn DA, Carpenter PA, Pavletic SZ, Martin PJ

Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist.

Wade PR, Palmer JM, McKenney S, Kenigs V, Chevalier K, Moore BA, Mabus JR, Saunders PR, Wallace NH, Schneider CR, Kimball ES, Breslin HJ, He W, Hornby PJ